World Health Organization has approved the first malaria vaccine Mosquirix for use among children in Africa.
Malaria is widespread in sub-Saharan Africa and is most deadly for children under five years of age.
WHO director-general Tedros Adhanom Ghebreyesus announced the decision to recommend the malaria vaccine based on an ongoing pilot program in Ghana, Kenya, and Malawi. Since 2019 more than 800,000 children have been administered the vaccine. So far, 2.3 million vaccine doses have been given to children across those three countries, and the study results show a favorable safety profile.